Covered recipient · General Payments record
JOCELYN ANDREA ESLICK
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$3,264.13
- Reported across 66 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,377.39 | 39 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $425.61 | 22 |
| Amgen Inc. | $396.12 | 7 |
| Acerta Pharma LLC | $280.28 | 5 |
| GlaxoSmithKline, LLC. | $156.08 | 4 |
| GENZYME CORPORATION | $119.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (39)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.58 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078542 | CMS |
| ABBVIE INC. | $18.86 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078544 | CMS |
| ABBVIE INC. | $4.62 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078546 | CMS |
| ABBVIE INC. | $4.91 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078548 | CMS |
| ABBVIE INC. | $18.45 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078550 | CMS |
| ABBVIE INC. | $4.88 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078552 | CMS |
| ABBVIE INC. | $29.71 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078554 | CMS |
| ABBVIE INC. | $122.62 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078556 | CMS |
| ABBVIE INC. | $1.96 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078558 | CMS |
| ABBVIE INC. | $16.19 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078560 | CMS |
| ABBVIE INC. | $13.22 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078562 | CMS |
| ABBVIE INC. | $96.16 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078564 | CMS |
| ABBVIE INC. | $1.84 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078566 | CMS |
| ABBVIE INC. | $13.60 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078568 | CMS |
| ABBVIE INC. | $14.38 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078570 | CMS |
| ABBVIE INC. | $17.29 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078572 | CMS |
| ABBVIE INC. | $1.49 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078574 | CMS |
| ABBVIE INC. | $7.72 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078576 | CMS |
| ABBVIE INC. | $2.63 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078578 | CMS |
| ABBVIE INC. | $12.03 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078580 | CMS |
| ABBVIE INC. | $14.08 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078582 | CMS |
| ABBVIE INC. | $3.39 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107078584 | CMS |
| Amgen Inc. | $8.93 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117247107 | CMS |
| Amgen Inc. | $20.12 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117247109 | CMS |
| Amgen Inc. | $121.10 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117247115 | CMS |
| Amgen Inc. | $8.69 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117247111 | CMS |
| Amgen Inc. | $111.61 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117549575 | CMS |
| Amgen Inc. | $18.89 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117247113 | CMS |
| Amgen Inc. | $106.78 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117247117 | CMS |
| AstraZeneca Pharmaceuticals LP | $119.21 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105774326 | CMS |
| AstraZeneca Pharmaceuticals LP | $115.25 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105778142 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.71 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104555090 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.64 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105348355 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.47 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105624383 | CMS |
| GENZYME CORPORATION | $119.30 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139876279 | CMS |
| GlaxoSmithKline, LLC. | $21.29 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115892327 | CMS |
| GlaxoSmithKline, LLC. | $19.42 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116564208 | CMS |
| GlaxoSmithKline, LLC. | $21.51 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116543294 | CMS |
| GlaxoSmithKline, LLC. | $93.86 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116684103 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.